This study is in progress, not accepting new patients
A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
a study on Ovarian Cancer
Summary
- Eligibility
- for females ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study started
- Principal Investigator
- Lee-May Chen
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
Details
- Status
- in progress, not accepting new patients
- Start Date
- Sponsor
- Tesaro, Inc.
- ID
- NCT02655016
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated